PH24358A - Sustained release matrix formulations - Google Patents
Sustained release matrix formulationsInfo
- Publication number
- PH24358A PH24358A PH36560A PH36560A PH24358A PH 24358 A PH24358 A PH 24358A PH 36560 A PH36560 A PH 36560A PH 36560 A PH36560 A PH 36560A PH 24358 A PH24358 A PH 24358A
- Authority
- PH
- Philippines
- Prior art keywords
- sustained release
- release matrix
- matrix formulations
- formulations
- sustained
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Cephalosporin Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US1991587A | 1987-02-27 | 1987-02-27 |
Publications (1)
Publication Number | Publication Date |
---|---|
PH24358A true PH24358A (en) | 1990-06-13 |
Family
ID=21795732
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PH36560A PH24358A (en) | 1987-02-27 | 1988-02-26 | Sustained release matrix formulations |
Country Status (26)
Country | Link |
---|---|
EP (1) | EP0280571B1 (el) |
JP (1) | JPH082793B2 (el) |
KR (1) | KR960005140B1 (el) |
CN (1) | CN1023765C (el) |
AR (1) | AR243376A1 (el) |
AT (1) | ATE92309T1 (el) |
AU (1) | AU604849B2 (el) |
CA (1) | CA1316110C (el) |
CY (1) | CY1741A (el) |
DE (2) | DE3882739T2 (el) |
DK (1) | DK175620B1 (el) |
EG (1) | EG18523A (el) |
ES (1) | ES2044825T3 (el) |
GR (1) | GR930300027T1 (el) |
HK (1) | HK125793A (el) |
HU (1) | HU202747B (el) |
IE (1) | IE61419B1 (el) |
IL (1) | IL85538A (el) |
LV (1) | LV10184B (el) |
MX (1) | MX10558A (el) |
NZ (1) | NZ223619A (el) |
PH (1) | PH24358A (el) |
PT (1) | PT86831B (el) |
RU (1) | RU1831337C (el) |
UA (1) | UA18251A (el) |
ZA (1) | ZA881301B (el) |
Families Citing this family (31)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE185267T1 (de) * | 1990-05-04 | 1999-10-15 | Perio Prod Ltd | System zur arzneistoffabgabe im colon |
IL98087A (en) * | 1990-05-04 | 1996-11-14 | Perio Prod Ltd | Preparation for dispensing drugs in the colon |
FR2667242B1 (fr) * | 1990-09-28 | 1994-11-25 | Rhone Poulenc Sante | Nouvelles formes orales a liberation prolongee avec un temps de latence au niveau stomacal amoindri. |
IT1250654B (it) * | 1991-07-08 | 1995-04-21 | Farcon Ag | Metodo per la preparazione di forme farmaceutiche orali a rilascio prolungato contenenti sostanze attive a solubilita' dipendente dal valore di ph. |
AU693483B2 (en) * | 1993-10-22 | 1998-07-02 | Tsumura & Co. | Base for sustained-release preparation, sustained-release preparation, and process for producing the preparation |
US5695781A (en) * | 1995-03-01 | 1997-12-09 | Hallmark Pharmaceuticals, Inc. | Sustained release formulation containing three different types of polymers |
US5840332A (en) * | 1996-01-18 | 1998-11-24 | Perio Products Ltd. | Gastrointestinal drug delivery system |
RU2192245C2 (ru) * | 1996-05-13 | 2002-11-10 | Новартис Консьюмер Хелс С.А. | Трансбуккальная система доставки |
CA2209868C (en) * | 1997-08-15 | 2001-08-14 | Bernard Charles Sherman | Pharmaceutical compositions comprising cefuroxime axetil |
CA2322432C (en) * | 1998-03-03 | 2005-12-20 | Daewoong Pharmaceutical Co., Ltd. | Pharmaceutical composition containing cefuroxime axetil stable for moisture absorption |
KR100296413B1 (ko) * | 1998-04-01 | 2001-11-14 | 김선진 | 세파클러함유서방성정제 |
AT413647B (de) * | 1998-11-26 | 2006-04-15 | Sandoz Ag | Verwendung eines copolymerisats aus 1-vinyl-2-pyrrolidon und vinylacetat zur herstellung von cefuroximaxetil-hältigen tabletten |
EP1970052A2 (en) | 1999-02-09 | 2008-09-17 | Pfizer Products Inc. | Basic drug compositions with enhanced bioavailability |
KR100647901B1 (ko) * | 1999-07-09 | 2006-11-17 | 보령제약 주식회사 | 세파클러-함유 서방성 약제조성물 및 그의 제조방법 |
AT500063A1 (de) * | 1999-11-23 | 2005-10-15 | Sandoz Ag | Beschichtete tablettenkerne |
AU774993B2 (en) | 1999-12-28 | 2004-07-15 | Kimberly-Clark Worldwide, Inc. | Use-dependent indicator system for absorbent articles |
MXPA02006424A (es) | 1999-12-28 | 2002-11-29 | Kimberly Clark Co | Pano limpiador antimicrobial de liberacion controlada para superficies duras. |
US6372252B1 (en) * | 2000-04-28 | 2002-04-16 | Adams Laboratories, Inc. | Guaifenesin sustained release formulation and tablets |
US6419954B1 (en) * | 2000-05-19 | 2002-07-16 | Yamanouchi Pharmaceutical Co., Ltd. | Tablets and methods for modified release of hydrophilic and other active agents |
ATE266407T1 (de) | 2000-10-30 | 2004-05-15 | Lupin Ltd | Schnell zerfallende cefuroxim axetil enthaltende arzneizusammensetzung mit verzögerter wirkstoffabgabe |
ES2645930T3 (es) | 2003-01-03 | 2017-12-11 | Supernus Pharmaceuticals, Inc. | Utilización de una mezcla de dos o más materiales entéricos para regular la liberación de fármacos a través de una membrana o matriz para terapias sistémicas |
DE102005019458A1 (de) * | 2005-04-25 | 2006-10-26 | Grünenthal GmbH | Darreichungsform mit verbesserter Freisetzung von Cefuroximaxetil |
EP1837020A1 (en) * | 2006-03-24 | 2007-09-26 | Bioalliance Pharma | Mucosal bioadhesive slow release carrier for delivering active principles |
ES2360423T3 (es) | 2006-04-26 | 2011-06-03 | Supernus Pharmaceuticals, Inc. | Preparaciones de liberación controlada de oxcarbazepina que tienen perfil de liberación sigmoidal. |
US8202456B2 (en) | 2006-11-13 | 2012-06-19 | Kyorin Pharmaceutical Co., Ltd. | Method for preparing sustained release tablet |
KR20120003906A (ko) | 2009-03-27 | 2012-01-11 | 교린 세이야꾸 가부시키 가이샤 | 염기성 첨가제를 함유하는 매트릭스형 서방성 제제 |
US20120040008A1 (en) * | 2010-08-11 | 2012-02-16 | Ashish Chatterji | Pharmaceutical compositions of metabotropic glutamate 5 receptor (mglu5) antagonists |
US20120039999A1 (en) * | 2010-08-11 | 2012-02-16 | Ashish Chatterji | Pharmaceutical compositions of metabotropic glutamate 5 receptor (mglu5) antagonists |
CN101912373B (zh) * | 2010-08-24 | 2012-01-04 | 北京京丰制药有限公司 | 稳定的头孢克洛分散片及其制备方法 |
CN106456681B (zh) * | 2014-06-10 | 2019-11-22 | 狮王株式会社 | 含有清酒酵母的片剂 |
JP7426685B2 (ja) * | 2018-06-14 | 2024-02-02 | 株式会社東洋新薬 | 錠剤 |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NZ195933A (en) * | 1980-01-11 | 1982-11-23 | Boots Co Ltd | Sustained-release pharmaceutical compositions in tablet form |
JPS6024765B2 (ja) * | 1981-11-27 | 1985-06-14 | 辰巳化学株式会社 | セフアレキシンの持続性製剤の製造方法 |
JPS601128A (ja) * | 1983-06-15 | 1985-01-07 | Shionogi & Co Ltd | 作用持続型セフアクロル製剤 |
LU85058A1 (fr) * | 1983-10-24 | 1985-06-19 | Pharlyse | Comprimes pharmaceutiques a liberation prolongee,leur preparation et leur utilisation |
US4520009A (en) * | 1983-11-28 | 1985-05-28 | Verex Laboratories, Inc. | Sustained released aspirin formulation |
US4680323A (en) * | 1983-12-01 | 1987-07-14 | Hans Lowey | Method and composition for the preparation of controlled long-acting pharmaceuticals for oral administration |
JPS61286330A (ja) * | 1985-06-11 | 1986-12-16 | Teijin Ltd | 経口徐放性製剤 |
JPS62120315A (ja) * | 1985-11-20 | 1987-06-01 | Shin Etsu Chem Co Ltd | 経口投与型徐放性錠剤の製造方法 |
-
1988
- 1988-02-24 IL IL85538A patent/IL85538A/xx not_active IP Right Cessation
- 1988-02-24 NZ NZ223619A patent/NZ223619A/xx unknown
- 1988-02-24 CA CA000559656A patent/CA1316110C/en not_active Expired - Lifetime
- 1988-02-24 ZA ZA881301A patent/ZA881301B/xx unknown
- 1988-02-25 DK DK198800980A patent/DK175620B1/da not_active IP Right Cessation
- 1988-02-25 AU AU12193/88A patent/AU604849B2/en not_active Expired
- 1988-02-25 AR AR88310159A patent/AR243376A1/es active
- 1988-02-25 PT PT86831A patent/PT86831B/pt not_active IP Right Cessation
- 1988-02-25 MX MX1055888A patent/MX10558A/es unknown
- 1988-02-25 EG EG109/88A patent/EG18523A/xx active
- 1988-02-26 RU SU884355273A patent/RU1831337C/ru active
- 1988-02-26 KR KR1019880001974A patent/KR960005140B1/ko not_active IP Right Cessation
- 1988-02-26 PH PH36560A patent/PH24358A/en unknown
- 1988-02-26 UA UA4355273A patent/UA18251A/uk unknown
- 1988-02-26 ES ES88301684T patent/ES2044825T3/es not_active Expired - Lifetime
- 1988-02-26 IE IE54588A patent/IE61419B1/en not_active IP Right Cessation
- 1988-02-26 CN CN88101062A patent/CN1023765C/zh not_active Expired - Lifetime
- 1988-02-26 DE DE88301684T patent/DE3882739T2/de not_active Expired - Lifetime
- 1988-02-26 DE DE198888301684T patent/DE280571T1/de active Pending
- 1988-02-26 HU HU88930A patent/HU202747B/hu unknown
- 1988-02-26 AT AT88301684T patent/ATE92309T1/de not_active IP Right Cessation
- 1988-02-26 JP JP63045703A patent/JPH082793B2/ja not_active Expired - Lifetime
- 1988-02-26 EP EP88301684A patent/EP0280571B1/en not_active Expired - Lifetime
-
1993
- 1993-05-24 GR GR930300027T patent/GR930300027T1/el unknown
- 1993-06-08 LV LVP-93-513A patent/LV10184B/lv unknown
- 1993-11-11 HK HK1257/93A patent/HK125793A/xx not_active IP Right Cessation
-
1995
- 1995-02-17 CY CY174195A patent/CY1741A/xx unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR243376A1 (es) | Un procedimiento para preparar medicamentos tableteados. | |
NZ225101A (en) | Sustained release composition | |
AR243378A1 (es) | Procedimiento para preparar una formulacion farmaceutica de liberacion prolongada. | |
EP0306236A3 (en) | Controlled release formulations | |
NZ225402A (en) | Oral sustained release acetaminophen formulations | |
ZA878499B (en) | Transdermal contraceptive formulations | |
PH24205A (en) | Sustained release dosage forms | |
EP0318899A3 (en) | Release agent composition | |
AU7942087A (en) | Sustained release formulations | |
IL88148A0 (en) | Somatotropin sustained release formulations | |
IE871503L (en) | Sustained release formulations | |
SG27194G (en) | Sustained release etodaloc | |
ZA896012B (en) | Controlled release formulations | |
IE872675L (en) | Sustained release pharmaceutical | |
AU663388B2 (en) | Sustained release formulations | |
GB8922061D0 (en) | Controlled release formulations | |
IE860577L (en) | Sustained release composition | |
GB8705453D0 (en) | Insecticidal formulations | |
GB8729673D0 (en) | Formulations | |
GB8908838D0 (en) | Sustained release | |
IE862339L (en) | Disc-like sustained release formulations | |
IE880658L (en) | Sustained release compositions | |
IE881744L (en) | Acaricide formulations | |
ZA898470B (en) | Sustained release preparations | |
GB8716488D0 (en) | Release mechanism |